Literature DB >> 20831663

Kinetic epidemiological model for elucidating sexual difference of hypertension (KCIS no.20).

Amy M-F Yen1, Tony H-H Chen.   

Abstract

BACKGROUND: Woman have lower rate of hypertension than man but it is still elusive how such gender difference can be explained by kinetic epidemiological curves.
OBJECTIVE: The aim of this paper was to develop a multi-state model for delineating the kinetic epidemiology of hypertension according to the Seventh Report of the Joint National Committee (JNC 7) classification criteria by gender, and to derive gender-specific kinetic curves.
METHODS: We used data from a population-based screening programme with 42,027 participants to fit a four-state Markov model corresponding to the classification of hypertension from the JNC 7.
RESULTS: The young man had higher progression rate but lower regression rate for the movement between normal and pre-hypertension than the young woman. Such gender difference disappeared after 50 years old. The mean sojourn time of pre- and stage 1 hypertension for man and stage 1 for woman was approximately 5 years. However, the corresponding figure for pre-hypertension for woman was 25 years at age 30, 10 years at age 40 and 5 years afterwards.
CONCLUSION: Elucidating the kinetic epidemiological curves of hypertension explains higher prevalence rate in young man than woman. These findings fit with the role of sex hormones regulating blood pressure demonstrated in the animal model.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20831663     DOI: 10.1111/j.1365-2753.2010.01379.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  1 in total

1.  Dynamics of detailed components of metabolic syndrome associated with the risk of cardiovascular disease and death.

Authors:  Ting-Yu Lin; Kuo-Liong Chien; Yueh-Hsia Chiu; Pi-Chun Chuang; Ming-Fang Yen; Hsiu-Hsi Chen
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.